An advanced hybrid closed-loop insulin delivery system is safe to use for pregnant women with type 1 diabetes and may provide ...

We assess the options when it comes to staying loyal to your camera brand, switching over or straddling multiple systems ...

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as ...

The new BRU-78 Dual Carriage System allows the MQ-9 Reaper to carry two bombs on a single hardpoint, doubling the number of ...

Novo Nordisk already has a fairly well-stocked pipeline of candidates, but one of its near-term hopes – CagriSema, which combines semaglutide with dual amylin and calcitonin receptor agonist ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Navitas Semiconductor has announced what it believes are the world’s first production-released 650 V bi-directional GaNFast ...

TOKYO: Foreign visitors heading to Japan should prepare for potentially spending more, as the country is set to introduce a “two-tier” pricing system at major tourist attractions from July.

Novo Nordisk launched a direct-to-consumer program last week to sell Wegovy at a reduced price for people who are uninsured or insured on commercial plans that don't cover the obesity drug. Through ...

Viking is set to challenge Eli Lilly and Novo Nordisk with its investigational oral obesity drug. Credit: SOPA Images via Getty Images. Viking Therapeutics has inked a $150m multi-year manufacturing ...